Terumo Corp.: FDA filings under this applicant name

FDA lists 34 510(k) clearances under the applicant name “Terumo Corp.” (first 1991, latest 2026), across 19 product codes in 5 review panels. Median 510(k) review time under this name: 54 days. Since 2017 the median was 174 days, against 140 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under Terumo, based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
20122130
2013226
20140—
20150—
20160—
20171217
20182140
20191146
20200—
20210—
20220—
20230—
20242196
20252193
20261247

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Terumo Corp. took a median 174 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 140 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
DTZOxygenator, Cardiopulmonary Bypass66
DQXWire, Guide, Catheter44
DQOCatheter, Intravascular, Diagnostic33
FOZCatheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days33
FMFSyringe, Piston22
FMINeedle, Hypodermic, Single Lumen22
OCYEndoscopic Guidewire, Gastroenterology-Urology22
DQYCatheter, Percutaneous11
DTLAdaptor, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass11
DTNReservoir, Blood, Cardiopulmonary Bypass11

Plus 9 more product codes.

Review panels

Most recent Terumo Corp. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K252295RyureiLOX2026-03-27247
K250700Pen Injector Needle 32.5FMI2025-11-21259
K250751DualView CatheterDQO2025-07-17127
K240818R2P Radifocus Glidewire AdvantageDQX2024-11-26246
K240859Glidewire GT-RDQX2024-08-21146
K190427ImmuciseFMF2019-07-18146
K181369Immucise Intradermal Injection SystemFMI2018-11-13174
K173799NaviCross 0.018DQY2018-03-29105
K170417Glidewire GTDQX2017-09-15217
K130493CAPIOX RX05 HOLLOW FIBER OXYGENATOR/RESERVOIRDTZ2013-03-1315

24 earlier clearances. See the full list in Caduvo.

Recalls

openFDA lists no recalls under a recalling firm named Terumo Corp..

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Related HCPCS codes

HCPCS Level II codes whose descriptors match the device names of the product codes filed under Terumo Corp. (a text match, not an official crosswalk):

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Terumo Corp.?

FDA lists 34 510(k) clearances under the applicant name “Terumo Corp.” (first 1991, latest 2026), across 19 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Terumo Corp.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Terumo Corp. is 54 days. Since 2017: 174 days, versus 140 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Terumo Corp.?

The most frequent FDA product codes under this applicant name are DTZ (Oxygenator, Cardiopulmonary Bypass, 6); DQX (Wire, Guide, Catheter, 4); DQO (Catheter, Intravascular, Diagnostic, 3).

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.

All FDA device companies · FDA product code lookup